Hosted on MSN1mon
FDA grants ODD status to Zai Lab’s lung cancer treatment
It is being assessed both as a single agent and in conjunction with the immune checkpoint inhibitor atezolizumab for ... ventilator-associated bacterial pneumonia. "FDA grants ODD status to ...
ascopubs.org15d
COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts
Relevance section written by JCO Associate Editor Gary K. Schwartz, MD, FASCO. The phase Ib COSMIC-021 study evaluated cabozantinib plus atezolizumab in patients with advanced solid tumors. Presented ...
Medpage Today on MSN5mon
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
Patients received 35 cycles of intravenous atezolizumab and obinutuzumab ... one from sepsis and one from fungal pneumonia.